AI-Developed Lung Drug Shows Promise in Reversing Aging Markers
Researchers have reported that a novel lung medication discovered through artificial intelligence successfully reversed key biological aging markers in clinical studies. The findings highlight the growing potential of AI-driven drug discovery in developing targeted anti-aging therapies.
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (32/100)Sources
Insilico's Lung Drug Reverses Aging Markers in Study
Alex Zhavoronkov, Founder and CEO of Insilico Medicine, discusses the implications after an AI-discovered lung drug developed by his company showed promise in reversing biological signs of aging. (Source: Bloomberg)
Read full article →AI-discovered lung drug reverses aging markers in study
An experimental lung disease drug developed using artificial intelligence showed promise in reversing biological signs of aging, pointing to broader potential use of the treatment, according to its developer.
Read full article →Coverage Timeline
Related Stories
China Develops Humanoid Robots for Combat and Mass Production
11m ago
Boston Scientific Warns of Missed 2026 Targets After Cyberattack
34m ago
Israel Says Source Code for ‘Achilles Shield’ to Stay Under Greek Control
35m ago
UK Air Traffic Control Glitch Causes Flight Chaos and Hundreds of Cancellations
44m ago